Science 37 Holdings, Inc.

Science 37 Holdings, Inc., formed through the combination of LifeSci Acquisition 2 Corp (Nasdaq: LSAQ) with decentralized clinical trial technology company Science 37, completed its de-SPAC merger in October 2021 after LSAQ's IPO earlier that same year. The blank-check vehicle was sponsored by LifeSci Capital, a life sciences-focused investment firm with prior SPAC experience. The combined company operates in the healthcare technology and clinical research sector, providing a technology-enabled platform designed to conduct decentralized and hybrid clinical trials. The 10-Q filed November 15, 2021, under accession 0001104659-21-138682, represents one of the first post-merger quarterly disclosures from Science 37 Holdings as a public company. Sign up at SpacDesk for full filing history, deal timelines, and sponsor analytics on this and hundreds of other SPAC transactions.